1. Mills, K. T., Stefanescu, A., & He, J. (2020). The global epidemiology of hypertension. Nature Reviews Nephrology, 5, 1–5.
2. Venkitachalam, L., Wang, K., Porath, A., Corbalan, R., Hirsch, A. T., Cohen, D. J., Smith, S. C., Jr., Ohman, E. M., Steg, P. G., Bhatt, D. L., Magnuson, E. A., & REACH Registry Investigators. (2012). Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance. Circulation, 125(15), 1858–1869.
3. https://www.who.int/news-room/fact-sheets/detail/hypertension. Accessed on 18 Aug 2020
4. Zhou, B., Bentham, J., Di Cesare, M., Bixby, H., Danaei, G., Cowan, M. J., Paciorek, C. J., Singh, G., Hajifathalian, K., Bennett, J. E., & Taddei, C. (2017). Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19· 1 million participants. The Lancet, 389(10064), 37–55.
5. Taddei, C., Zhou, B., Bixby, H., & NCD Risk Factor Collaboration (NCD-RisC). (2020). Repositioning of the global epicentre of non-optimal cholesterol. Nature, 4(582), 73–77.